E1A recruits hPaf1 to HAdV early gene promoters via hBre1. by Gregory J. Fonseca (421739)

“…Data was normalized to ΔE1A HAdV and a non-specific antibody control. (D and E) hPaf1 recruitment to the E3 and E4 promoter requires hBre1. …”

Decrease in extracellular Zn²⁺ in the hippocampus by zinc chelators. by Atsushi Takeda (18203)

“…<p>Hippocampal slices were prepared 2 h after i.p. injection of vehicle (A, n = 7) or CQ (30 mg/kg, B, n = 5) into NER, and 3 h after i.p. injection of vehicle (C, n = 7) or TPEN (1 mg/kg, D, n = 8) into NER. …”

Cholesterol efflux capacity is decreased in coronary artery disease patients in China. by Guisong Wang (1627384)

“…<p>(A) Cholesterol efflux capacity (CEC) in coronary artery disease (CAD) subjects compared to healthy controls (Non CAD) cohort in the entire cohort. …”

Flow cytometry analysis of Annexin V/FITC-PI on SW480 and HCT116 cells treated with negative control, THC, βCD-THC inclusion complex, and camptothecin. by Zhi Xuan Low (19270163)

Disruption of poly-ADP-ribosylation decreases nucleolar CTCF, disrupts nucleolar structure, and increases <i>rDNA</i> expression. by Paola A. Guerrero (357587)

Enhanced cAMP production in ADL neurons decreases intestinal fat. by Rosalind Hussey (4033091)

“…Relative to non-transgenic controls (NT, light gray bar), transgenic animals (T, dark gray bar) bearing <i>gpa-3</i> antisense in ADL neurons had a significant decrease in body fat. …”

Identification of a Hydroxypyrimidinone Compound (<b>21</b>) as a Potent APJ Receptor Agonist for the Potential Treatment of Heart Failure by Wei Meng (505670)

“…Due to the increased polarity at C2, the permeability for these compounds decreased. Further adjustment of the polarity by replacing the N1 2,6-dimethoxyphenyl group with a 2,6-diethylphenyl group and reoptimization for the potency of the C5 pyrroloamides resulted in potent compounds with improved permeability. …”

Identification of a Hydroxypyrimidinone Compound (<b>21</b>) as a Potent APJ Receptor Agonist for the Potential Treatment of Heart Failure by Wei Meng (505670)

“…Due to the increased polarity at C2, the permeability for these compounds decreased. Further adjustment of the polarity by replacing the N1 2,6-dimethoxyphenyl group with a 2,6-diethylphenyl group and reoptimization for the potency of the C5 pyrroloamides resulted in potent compounds with improved permeability. …”

Identification of a Hydroxypyrimidinone Compound (<b>21</b>) as a Potent APJ Receptor Agonist for the Potential Treatment of Heart Failure by Wei Meng (505670)

“…Due to the increased polarity at C2, the permeability for these compounds decreased. Further adjustment of the polarity by replacing the N1 2,6-dimethoxyphenyl group with a 2,6-diethylphenyl group and reoptimization for the potency of the C5 pyrroloamides resulted in potent compounds with improved permeability. …”

The decrease in hBMVEC death is associated with reduced activation of Caspase-3. by Simona F. Spampinato (773594)

Fig 3 - by Debarpan Dhar (724473)

N100 amplitude decrease during 1 Hz-rTMS. by Christian Helfrich (297785)

“…Electrodes C3, CP3’ and CP5’ were pooled. <i>Left</i>: TMS-evoked N100 amplitude continuously decreased during the stimuli 1–500. …”

Decreased expression of βKlotho in HCC tissue and hepatoma cell lines. by Xiaoming Ye (278192)

Hsp90 interacts with BMS1 and decreased Hsp90 function compromises 80S ribosome and polysome stability at 16°C. by Eric A. Franzosa (130063)

Quantification of apoptosis and necrosis by flow cytometry in CsA-treated HRE cells: Effect of MAGEH1 knockdown. by Gyu-Tae Shin (5819249)

Brain Weight (A), Body Weight (B), and Organ Weights (C), (D), and (E) at five weeks after hypoxia ischemia. by Pradilka N. Drunalini Perera (528914)

“…The treatment groups showed a slight decrease in pulmonary haemorrhage <b>(C)</b>. …”

SEM images of the samples (a) virgin sample (b) 0.4 wt. % <i>f-MWCNTs</i> (c) 0.5 wt. % <i>f—MWCNTs</i>. by Shaban Gul (14309526)

Apigenin decrease eosinophil infiltration in colonic tissues from HFD-mice. by Daniela Gentile (5089280)

<i>drp2b</i> shows increased ROS and decreased <i>PR1</i> mRNA to living <i>Pto</i> in a T3SS-independent manner. by John M. Smith (676719)

Gene expression response to USF depletion and IR. by Kimberly S. Bellingham-Johnstun (21714063)